Skip to main content
Valentina Nardi, MD, Pathology, Boston, MA, Massachusetts General Hospital

ValentinaNardiMD

Pathology Boston, MA

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant pathologist, Massachusetts General Hospital

Dr. Nardi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nardi's full profile

Already have an account?

  • Office

    Massachusetts General Hospital
    55 Fruit Street
    Boston, MA 02114
    Phone+1 617-726-2967
    Fax+1 617-726-7474
  • Is this information wrong?

Education & Training

  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2012 - 2013
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Hematopathology, 2010 - 2012
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2012
  • Univ Genoa- Fac Med
    Univ Genoa- Fac MedClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2024
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Pathology - Molecular Genetic
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Abstracts/Posters

  • Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera
    Valentina Nardi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Newly Characterized Mutation May Define a Novel Leukemia Subtype in Kids
    Newly Characterized Mutation May Define a Novel Leukemia Subtype in KidsFebruary 24th, 2022
  • Newly Characterized Mutation May Define Novel Pediatric AML Subtype
    Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
  • Case 37-2019: A 20-Month-Old Boy with Severe Anemia
    Case 37-2019: A 20-Month-Old Boy with Severe AnemiaNovember 28th, 2019

Hospital Affiliations